Equities

Taiwan Liposome Co Ltd

Taiwan Liposome Co Ltd

Actions
  • Price (EUR)3.94
  • Today's Change-0.10 / -2.48%
  • Shares traded0.00
  • 1 Year change-10.45%
  • Beta--
Data delayed at least 15 minutes, as of May 07 2021.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Taiwan Liposome Company, Ltd. is a Taiwan-based company principally engaged in the research and development and commercialization of lipid drug delivery systems. The Company is engaged in the development of special generic drugs, new formulas and new drugs using patents. The Company's therapeutic areas include pain management, eye diseases and cancer. Its anticancer medicine product named Lipo-Dox has been distributed in domestic and Asian markets.

  • Revenue in TWD (TTM)101.93m
  • Net income in TWD-981.52m
  • Incorporated1997
  • Employees88.00
  • Location
    Taiwan Liposome Co Ltd2FNo.3, Yuanqu Street, Nangang DistrictTAIPEI 115TaiwanTWN
  • Phone+886 226557377
  • Fax+886 226557366
  • Websitehttps://www.tlcbio.com/
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.